The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
May 1st 2024
Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine, discusses telehealth initiatives at Duke Health, as well as overcoming virtual challenges and barriers that underserved and underinsured patient populations who need diabetes care face.
Watch
Dr Susan Spratt Discusses Diabetes Management Services at Duke Health
September 17th 2023Susan Spratt, MD, senior medical director, Duke Population Health Management Office, breaks down the the prevalence of diabetes in the United States and discusses current diabetes initiatives at Duke Health.
Watch
Measuring Continuity of Care for Diabetes: Which Visits to Include?
This study examined how inclusion of different provider specialties affected Continuity of Care Index values, year-to-year stability, and association with emergency department visits.
Read More
Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes
Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.
Read More
Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary Update
Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.
Read More
Non–Face-to-Face Care Management and Service Utilization in Patients With Diabetes
CMS began reimbursement for non–face-to-face chronic care management in 2015, and results from Louisiana show that it increases outpatient visits but decreases inpatient and emergency department encounters.
Read More
Experts Call for Health System Action to Reduce Hypoglycemia Risk in Older Adults With Diabetes
August 10th 2023According to one panelist, the leading causes of hypoglycemia in older adults are insufficient nutrition and taking the wrong dose or type of insulin, both of which can be addressed at the patient and system level.
Read More
Cap on Out-of-Pocket Insulin Costs in Inflation Reduction Act Increased Prescription Fills
July 29th 2023Thousands more people filled their insulin prescriptions following the introduction of the cap in January 2023, especially compared to those who were not enrolled in Medicare, a new study finds.
Read More
SGLT2is Reduce Recurrent Gout Flare More Than DPP-4is in Patients With Diabetes, Study Says
July 27th 2023Initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2is) was associated with a 34% lower rate of recurrent gout flare compared with initiation of dipeptidyl peptidase 4 inhibitors (DPP-4is).
Read More
Dr Stephen Nicholls Discusses the Systemic Effects of Incretin-Based Therapies
July 24th 2023With a broad research focus on heart disease risk reduction through the development of novel treatment strategies, Stephen Nicholls, MBBS, PhD, Monash University and Victorian Heart Hospital, Melbourne, Australia. discusses contributions in the space from therapies with systemwide effects.
Watch
Rise in Pediatric Diabetes Cases Continued Through Year 2 of COVID-19 Pandemic
July 22nd 2023An analysis of electronic health record data recorded from 2018-2022 within Duke University Medical Center–affiliated diabetes care centers suggests the increased rate of new-onset type 1 and type 2 diabetes observed during the first year of the pandemic persisted through 2022.
Read More
FDA Approves Jardiance, Synjardy for Pediatric T2D
June 21st 2023Yesterday’s FDA approvals of a new indication for empagliflozin and combination empagliflozin with metformin hydrochloride for pediatric type 2 diabetes (T2D) provide a new class of oral drugs to treat the condition in children.
Read More
Diabetes, Gaps in Care Coordination, and Preventable Adverse Events
The authors examined the association of diabetes with self-reported gaps in care coordination and self-reported preventable adverse events using data from a national sample of older adults.
Read More
Dr Amal Agarwal: Value-Based Contracts Can Help Align Incentives in Dialysis
June 2nd 2023Amal Agarwal, DO, MBA, chief clinical officer at Monogram Health, explains the importance of value-based agreements in dialysis care, and the issue of dialysis prevalence among low-income and marginalized communities.
Watch
Stakeholder Analysis: Medicare Diabetes Prevention Program Awareness and Implementation
June 2nd 2023This article describes facilitators of and barriers to uptake of the underutilized Medicare Diabetes Prevention Program from the perspectives of health care providers and program suppliers in western Pennsylvania.
Read More